Marketa Chvojkova

Klecany, ST 25067, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

A new two-hit animal model for schizophrenia research: Consequences on social behavior.

A new two-hit animal model for schizophrenia research: Consequences on social behavior.

Journal: IBRO neuroscience reports
Published: February 11, 2025

Erratum to "Frentizole derivatives with mTOR inhibiting and senomorphic properties" [Biomed. Pharmacother. 167 (2023) 115600].

Erratum to "Frentizole derivatives with mTOR inhibiting and senomorphic properties" [Biomed. Pharmacother. 167 (2023) 115600].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 09, 2025

Corrigendum to Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists "Biomed. Pharmacother. 176 (2024) 116821".

Corrigendum to Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists "Biomed. Pharmacother. 176 (2024) 116821".

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 05, 2024

Memantine Administration Enhances Glutamatergic and GABAergic Pathways in the Human Hippocampus of Alzheimer's Disease Patients.

Memantine Administration Enhances Glutamatergic and GABAergic Pathways in the Human Hippocampus of Alzheimer's Disease Patients.

Journal: Proteomics
Published: August 29, 2024

Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects.

Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects.

Journal: European journal of medicinal chemistry
Published: May 31, 2024

Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists.

Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 18, 2024

Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition.

Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition.

Journal: European journal of medicinal chemistry
Published: November 28, 2023

Frentizole derivatives with mTOR inhibiting and senomorphic properties.

Frentizole derivatives with mTOR inhibiting and senomorphic properties.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 04, 2023

Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia.

Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia.

Journal: Biomolecules
Published: May 31, 2021

Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.

Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.

Journal: European journal of medicinal chemistry
Published: February 19, 2021

Effects of Dizocilpine, Midazolam and Their Co-Application on the Trimethyltin (TMT)-Induced Rat Model of Cognitive Deficit.

Effects of Dizocilpine, Midazolam and Their Co-Application on the Trimethyltin (TMT)-Induced Rat Model of Cognitive Deficit.

Journal: Brain sciences
Published: February 07, 2021

7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo.

7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo.

Journal: Biochemical pharmacology
Published: December 20, 2020
Showing 1-12 of 16

Last Updated: 09/26/2026